IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.
about
Cytokine-Induced Modulation of Colorectal CancerCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor MicroenvironmentSignaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCsNew insights into IL-12-mediated tumor suppression.Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment.CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceThe dichotomous pattern of IL-12r and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammation.Targeting the tumor microenvironment to enhance antitumor immune responsesSize does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity.Proton irradiation augments the suppression of tumor progression observed with advanced age.IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice.Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.Nuclear receptors as modulators of the tumor microenvironment.Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production.Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse modelInnate lymphoid cells in the initiation, regulation and resolution of inflammationThe immune network in thyroid cancerDownregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicityEmerging concepts and future challenges in innate lymphoid cell biologyA cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejectionSEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice.The impact of the immune system on tumor: angiogenesis and vascular remodeling.Natural killer cells and solid tumors.Innate immune cells in breast cancer--from villains to heroes?Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells.Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation.Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.Innate lymphoid cells involve in tumorigenesis.Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.TRUCKs: the fourth generation of CARs.Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.NK cells and type 1 innate lymphoid cells: partners in host defense.Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis.Purification and Adoptive Transfer of Group 3 Gut Innate Lymphoid Cells.
P2860
Q26752374-6517A578-0882-42B9-91B2-B1B2496CA258Q28077126-64DC4D3B-D8F6-43F0-BEA6-8DEA26F26876Q28253084-0AFEC977-F856-4866-AB5B-7604E1569CEBQ34055620-0FB19647-3A47-43EB-83CA-698A6DB5BB3DQ34436897-404F9169-B463-497C-B166-168FE3A40342Q34757266-30455EB9-35AD-4088-9B66-12BB17CE96EFQ35015717-9A8DAA2A-7FC6-4AA6-9CE2-AF4AC4A3562BQ35106661-F70D3A3B-CE39-4435-86B1-2E11D177F187Q35176307-DEA0C66C-A149-4204-B319-49466FFADF1CQ35376137-1FED1467-C723-4E62-ACB4-F05F372A5FB2Q35526292-63BA618E-E455-4867-9768-6C0492324CBFQ35578622-000D097B-DE68-4043-9126-35A8022D542FQ35612643-D5E16D27-0E46-4EE2-99C9-3DC703AE51FAQ35939476-8146D34F-A589-4D62-B1F2-9E79A895535BQ36109555-197D0A41-718E-4AD6-A82B-5479FFCF17E0Q36127288-E27208CC-2B8B-48B1-ADBA-51F810FA7F34Q36401731-DF5BA8BF-3DD9-458E-A36B-7C79DF877411Q36671364-3DE96419-B11F-4892-B65B-0EE8014E75D6Q36822687-56E05A99-6AB6-4354-8D43-F259ECD7F284Q36908615-B3D7CF7E-3DC3-45B7-B2F1-81C08195F10BQ37079138-18B3E393-568D-41BC-9C5C-1CB2A5422D17Q37081973-120221B0-F338-4BA4-AEDB-614A609B7FC0Q37346684-FBB078E9-2AA2-401E-8D33-2827739ED928Q37362636-70F6A68E-FAC5-4E22-9012-C626CB3BA768Q37397827-3DF154C0-D6CD-4777-92C0-FDBE3FC96C83Q37580265-053C94E4-D111-4974-9BAD-10391C1DCB9BQ37702536-E5E0BA42-5A2D-4CB2-BFED-CE56AC19C10DQ37866598-83206D4D-E078-4C8A-A3BE-0AE1EFAE7E42Q37905673-914A3B93-C608-4611-88E3-AD7E5D9EEC8CQ37929639-3A5F5BDC-6030-4CAC-B1B1-A065C16B4A51Q37933845-9747C3EC-A5A4-4443-9447-94793C1CD95BQ38170498-0A81B038-3047-4FE0-8222-7A78D8ED59D8Q38325566-503A91AB-32B7-4EA0-B330-E61AFC2E0EF9Q38444161-92565BF8-8950-40F9-BB35-6FAB1376B16DQ38488557-4399D20D-3DC0-4606-8BC8-5386D66C9BE7Q38602944-FC78EEAD-A7D9-4E91-B1A5-1C27E453DD96Q38833469-0498FB95-20DD-4694-A037-7F537F87791DQ38872138-32DE6D8A-B931-414E-ABF7-595F3ECC2DD1Q38872144-1553A00F-E4E9-4D4B-9520-0A7F246632B1Q40651293-6FBDCE14-864C-46C7-88D9-1E88AAAF2BFA
P2860
IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@en
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@nl
type
label
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@en
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@nl
prefLabel
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@en
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@nl
P2093
P2860
P356
P1433
P1476
IL-12 initiates tumor rejectio ...... l cytotoxicity receptor NKp46.
@en
P2093
Burkhard Becher
Elisabeth Saller
Glen Kristiansen
Johannes vom Berg
Maya Eisenring
P2860
P304
P356
10.1038/NI.1947
P407
P577
2010-10-10T00:00:00Z